Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Kalkine Ca

Published November 3, 2026 · Updated November 4, 2026

Bright Minds Biosciences Inc. Faces Sharp Decline Amid Clinical Stage Pressures and ...

Read the full story at Kalkine Ca

biotech firms. Psychedelic and Serotonergic Sector Sentiment Shift: The broader category of psychedelic -adjacent and serotonergic therapeutic.

Surfaced by this Google Alert

  • Psychedelic biotech